The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial -
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks - ScienceDirect
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 ( SGLT2) Inhibitors: A State-of-the-Art Review | JACC: Basic to Translational Science
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors - Kidney International
Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition? - The Journal of Thoracic and Cardiovascular Surgery
SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature
Frontiers | Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk | Pharmacology
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity - Journal of Cardiology
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease - Metabolism - Clinical and Experimental
SGLT2 Inhibitors: A New Class of Diabetes Medications
Mode of action of SGLT2 inhibitors in the kidney. Copied with... | Download Scientific Diagram
Schematic diagram showing conventional mechanisms of action of SGLT2... | Download Scientific Diagram
![sglt-2_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/sglt2.png "sglt-2_inhibitors [TUSOM | Pharmwiki]")
sglt-2_inhibitors [TUSOM | Pharmwiki]
The mechanism of SGLT2 inhibition in glucose control - PACE-CME
SGLT2 inhibitors: a narrative review of efficacy and safety
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure | SpringerLink
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective - ScienceDirect
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors - Brown - 2019 - Diabetes, Obesity and Metabolism - Wiley Online Library
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits - The American Journal of Medicine
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes. | Semantic Scholar
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue | Hypertension
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks - Journal of Biological Chemistry
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus | Circulation
IJMS | Free Full-Text | SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits | HTML
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review | Journal of the American College of Cardiology
SciELO - Brasil - SGLT-2 inhibitors in diabetes: a focus on renoprotection SGLT-2 inhibitors in diabetes: a focus on renoprotection
